Champoux Jennifer
SEC CIK 2025233 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | COO | 66.7K | — | $311.3K | 13 | 2025-01-02 | 2026-07-15 |
Most active insiders at GLUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Janku Filip | Chief Medical Off | — | $1.38M |
| 2 | Warmuth Markus | Pres, CEO, Dir | — | $951.1K |
| 3 | Dunn Edmund | Principal Accounting Off | — | $483.1K |
| 4 | Townson Sharon | CSO | — | $423.9K |
| 5 | Manning Anthony M. | Dir | — | $411.2K |
| 6 | Champoux Jennifer | COO | — | $311.3K |
| 7 | Nickson Philip | Chief Business, Legal Off | — | $151.3K |
| 8 | Bowen Matthew | Principal Accounting Off | — | — |
| 9 | Behbahani Ali | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-16 16:10 | 2026-07-15 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | M - OptEx | $3.98 | +4,351 | 66.7K | +7% | +$17.3K |
| DT | 2026-07-16 16:10 | 2026-07-15 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | S - Sale+OE | $23.38 | -4,351 | 62.4K | -7% | -$101.7K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,175 | 64.5K | +3% | +$8,656 |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | S - Sale+OE | $20.00 | -2,175 | 62.4K | -3% | -$43.5K |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,176 | 64.5K | +3% | +$8,660 |
| DT | 2026-06-18 16:05 | 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | S - Sale+OE | $19.00 | -2,176 | 62.4K | -3% | -$41.3K |
| DT | 2026-05-28 19:10 | 2026-05-27 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,175 | 64.5K | +3% | +$8,656 |
| DT | 2026-05-28 19:10 | 2026-05-27 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | S - Sale+OE | $20.00 | -2,175 | 62.4K | -3% | -$43.5K |
| DT | 2026-05-26 16:05 | 2026-05-22 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,176 | 64.5K | +3% | +$8,660 |
| DT | 2026-05-26 16:05 | 2026-05-22 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | S - Sale+OE | $19.00 | -2,176 | 62.4K | -3% | -$41.3K |
| D | 2026-01-05 | 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | S - Sale | $15.17 | -2,629 | 62.4K | -4% | -$39.9K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | A - Grant | — | +35.0K | 65.0K | +117% | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | COO | A - Grant | — | +30.0K | 30.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations